Stocklytics Platform
Asset logo for symbol GHRS
GH Research PLC
GHRS41
$7.55arrow_drop_up0.53%$0.04
Asset logo for symbol GHRS
GHRS41

$7.55

arrow_drop_up0.53%

Performance History

Chart placeholder
Key Stats
Open$7.95
Prev. Close$8.00
EPS-0.67
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range7.39
8.66
52 Week Range5.05
14.99
Ratios
Revenue-
EBITDA Margin %-
EPS-0.67

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About GH Research PLC (GHRS)

GH Research PLC (ticker symbol: GHRS) is a leading biotech company focused on the development of innovative medical therapies. With a rich history and a strong presence in the healthcare industry, GH Research has consistently delivered groundbreaking advancements in medical science. This has propelled the company to become a key player in the global biopharmaceutical market. GH Research PLC has a long-standing commitment to research and development, striving to pioneer life-changing treatments that address unmet medical needs.
As of the latest available stock price history, GH Research PLC's (GHRS) stock has shown steady growth and resilience. This reflects the market's confidence in the company's potential and its ability to deliver value to shareholders. The stock is highly regarded among investors, with a strong performance that has outpaced the industry average. GH Research PLC's stock price has a solid track record of remaining competitive, making it an attractive investment option for those seeking long-term growth potential.
Websitecall_made
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Theis Terwey M.D.
Headquarters
Dublin
Employees
32
Exchange
NASDAQ
add GH Research PLC to watchlist

Keep an eye on GH Research PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is GH Research PLC's (GHRS) price per share?

The current price per share for GH Research PLC (GHRS) is $7.55. The stock has seen a price change of $0.04 recently, indicating a 0.53% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for GH Research PLC (GHRS)?

For GH Research PLC (GHRS), the 52-week high is $14.99, which is 98.54% from the current price. The 52-week low is $5.05, the current price is 49.5% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is GH Research PLC (GHRS) a growth stock?

GH Research PLC (GHRS) has shown an average price growth of -3.56% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying GH Research PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is GH Research PLC (GHRS) stock price performance year to date (YTD)?

As of the latest data, GH Research PLC (GHRS) has a year-to-date price change of 41.12%. Over the past month, the stock has experienced a price change of 8.01%. Over the last three months, the change has been -36.71%. Over the past six months, the figure is -33.19%.
help

Is GH Research PLC (GHRS) a profitable company?

GH Research PLC (GHRS) has a net income of -$35.59M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$41.22M. Furthermore, the EBITDA is -$45.53M.
help

What is the market capitalization of GH Research PLC (GHRS)?

GH Research PLC (GHRS) has a market capitalization of $425.07M. The average daily trading volume is 7.65, indicating the stock's liquidity and investor engagement.

News

Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why
May 13, 2024

Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why

Wall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should Know
May 10, 2024

Wall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should Know

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
EARNINGS RELEASES AND OPERATING RESULTS
May 3, 2024

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates

How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28%
Mar 5, 2024

How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28%

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
EARNINGS RELEASES AND OPERATING RESULTS
Feb 29, 2024

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
PATENTS
PRODUCT / SERVICES ANNOUNCEMENT
Jan 18, 2024

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level